Direxion Daily S&P Biotech Bull 3X Shares (LABU)
79.09
0.00 (0.00%)
Previous Close | 79.09 |
---|---|
Open | - |
Day's Range | N/A - N/A |
52 Week Range | 69.69 - 165.73 |
Volume | 6,570 |
Market Cap | 6.66M |
Dividend & Yield | 0.6000 (0.76%) |
1 Month Average Volume | 1,249,548 |
News & Press Releases

Are Verizon, Amazon, Cisco, Amgen, and the S&P Biotech Bull 3X Shares ETF poised to make your portfolio skyrocket? In this video, I take a closer look.
Via Talk Markets · September 22, 2024

Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment.
Via Benzinga · August 30, 2024

Wall Street piled up strong gains in yesterday’s trading session, with the S&P 500 hitting the 25th record high this year and the Nasdaq Composite Index touching another record.
Via Talk Markets · June 6, 2024

If you want to speculate on baskets of securities, then these best leveraged ETFs for April could be what the doctor ordered.
Via InvestorPlace · April 2, 2024

In this video, I discuss sector rotation out of technology stocks and into consumer staple, energy, and bank stocks.
Via Talk Markets · January 8, 2022

U.S. stocks rallied in February, with the S&P 500 and the Nasdaq Composite Index recording the best month in nearly a decade. Amid this environment, here are some of the best-performing leveraged equity ETFs that also experienced a positive month.
Via Talk Markets · March 2, 2024
This week, we take a look at small-cap and mid-cap stocks by using ETFs such as MDY and the leveraged ETF TNA. We also like the look of the LABU ETF.
Via Talk Markets · February 11, 2024

Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSELABU) if you want a speculative play in the biotechnology industry with amplified volatility.
Via MarketBeat · March 22, 2023

Robert Desmond looks at ETF and individual equities for the week just ended and gives his take on trading for the week to come.
Via Talk Markets · February 5, 2023

Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.
Via Talk Markets · January 17, 2023

Here are 3 stocks to buy on dips from scary geopolitical risks from Russia. These leveraged ETFs move extremely fast so bring your Dramamine.
Via InvestorPlace · February 22, 2022

China Tech (Alibaba) and Biotech have been the two least-loved sectors in recent weeks, but we believe this is changing.
Via Talk Markets · February 11, 2022

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.
Via InvestorPlace · January 13, 2022

The S&P 500 hit a record close last week, courtesy of a Santa Clause rally. Wall Street was charged-up with the S&P 500 (up 1.22%), the Dow Jones (up 0.15%), the Nasdaq Composite (up 3.12%) and the Russell 2000 (up 4.1%)
Via Talk Markets · December 28, 2021

Here are some best-performing leveraged equity ETFs from different corners of the market that gained in double digits in August.
Via Talk Markets · September 1, 2021

A discussion on trading hot IPOs and some of the issues that have arisen in recent times.
Via Talk Markets · August 7, 2021

A look at lessons learned from active trading of IPOs, ETFs, Russian Dolls, and a discussion on what might be the secret to trading-which ironically, is the polar opposite to trading.
Via Talk Markets · July 31, 2021

A look at lessons learned from active trading including what might be the secret to trading-which ironically is the polar opposite to trading.
Via Talk Markets · July 23, 2021

David Green made money day trading Bridgeline Digital Inc (NASDAQ:
Via Benzinga · July 6, 2021

A revisit using volatility to let us know when the elusive
Via Talk Markets · June 11, 2021

The Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) seeks the daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Index for a single day.
Via Talk Markets · June 8, 2021

The biotechnology sector has been on fire thanks to news from Biogen Inc. (NASDAQBIIB). The FDA approved its controverisal drug that can treat Alzheimer’s Disease.
Not...
Via Benzinga · June 8, 2021

In this video, we review the CrowdStrike stock earnings trade. We also review our top five stocks for the new trading week.
Via Talk Markets · June 6, 2021

Humanigen Inc. (NASDAQHGEN) shares made gains Wednesday
following the publication of results from a Phase 3 randomized double-blind placebo-controlled study.
The...
Via Benzinga · May 5, 2021